Your session is about to expire
← Back to Search
Cognitive Training
Computer Cognitive Training for Post-COVID Syndrome (PACS-Cog Trial)
N/A
Recruiting
Led By Raymond L Ownby, MD, PhD
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Persons with a history of COVID-19 infection confirmed through screening of symptom pattern or testing and report of mental symptoms (difficulties in attention, memory, or executive functions such as coordinating two activities at once) more than 30 days after resolution of the initial acute infection.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three weeks
Awards & highlights
PACS-Cog Trial Summary
This trial will test if a computer game can help people with COVID-related cognitive issues.
Who is the study for?
This trial is for individuals who had COVID-19 and are experiencing ongoing cognitive symptoms like trouble with attention, memory, or multitasking more than a month after their initial recovery. Participants must be able to give informed consent and cooperate with the study requirements.Check my eligibility
What is being tested?
The study is testing a game-based computer program designed to improve thinking skills in people suffering from long-term cognitive issues following COVID-19 infection. It aims to see if this digital cognitive training is practical, enjoyable, and effective.See study design
What are the potential side effects?
Since the intervention involves non-invasive cognitive training games on a computer, there are no direct physical side effects expected from participating in this trial.
PACS-Cog Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had COVID-19 and have experienced mental symptoms like memory or attention issues more than 30 days after recovering.
PACS-Cog Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ three weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Technology Acceptance Model Questionnaire, Usefulness subscale
Secondary outcome measures
Cognitive Failures Questionnaire
Trail Making Test, Part B
PACS-Cog Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive TrainingExperimental Treatment1 Intervention
Participants in this condition will received game-based cognitive training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
2008
Completed Phase 3
~4100
Find a Location
Who is running the clinical trial?
Nova Southeastern UniversityLead Sponsor
89 Previous Clinical Trials
11,633 Total Patients Enrolled
Raymond L Ownby, MD, PhDPrincipal InvestigatorNova Southeastern University
5 Previous Clinical Trials
544 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am mentally capable of understanding and consenting to participate in this study.I had COVID-19 and have experienced mental symptoms like memory or attention issues more than 30 days after recovering.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an ongoing recruitment of participants for this research?
"Affirmative. The clinical trial, initially posted on April 26th 2022 and recently updated on August 9th 2022, is actively searching for 10 participants from 1 medical centre. This information can be found via the clinicaltrials.gov website."
Answered by AI
What is the current scope of participation for this research?
"Affirmative, the information available on clinicaltrials.gov indicates that this research is currently recruiting. The trial was originally listed on April 26th 2022 and has since been refreshed as of August 9th 2022. Ten patients are sought from one medical facility for enrollment in this experiment."
Answered by AI
Share this study with friends
Copy Link
Messenger